Immune-Related Adverse Events Associated with Anti-PD-1/PD-L1 Treatment for Malignancies: A Meta-Analysis | |
Wang, Peng-Fei; Chen, Yang; Song, Si-Ying; Wang, Ting-Jian; Ji, Wen-Jun; Li, Shou-Wei; Liu, Ning; Yan, Chang-Xiang | |
2017 | |
卷号 | 8 |
关键词 | Anti-PD-1 antibodies immune-related adverse events immunotherapy oncology nivolumab |
ISSN号 | 1663-9812 |
DOI | 10.3389/fphar.2017.00730 |
URL标识 | 查看原文 |
收录类别 | SCIE |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/6363633 |
专题 | 中国医学科学院 北京协和医学院 |
推荐引用方式 GB/T 7714 | Wang, Peng-Fei,Chen, Yang,Song, Si-Ying,et al. Immune-Related Adverse Events Associated with Anti-PD-1/PD-L1 Treatment for Malignancies: A Meta-Analysis[J],2017,8. |
APA | Wang, Peng-Fei.,Chen, Yang.,Song, Si-Ying.,Wang, Ting-Jian.,Ji, Wen-Jun.,...&Yan, Chang-Xiang.(2017).Immune-Related Adverse Events Associated with Anti-PD-1/PD-L1 Treatment for Malignancies: A Meta-Analysis.,8. |
MLA | Wang, Peng-Fei,et al."Immune-Related Adverse Events Associated with Anti-PD-1/PD-L1 Treatment for Malignancies: A Meta-Analysis".8(2017). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论